122 related articles for article (PubMed ID: 37943051)
21. Identification of neuroblastoma cell lines with uncommon TAZ
Canzonetta C; Pelosi A; Di Matteo S; Veneziani I; Tumino N; Vacca P; Munari E; Pezzullo M; Theuer C; De Vito R; Pistoia V; Tomao L; Locatelli F; Moretta L; Caruana I; Azzarone B
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33452207
[TBL] [Abstract][Full Text] [Related]
22. Protein tyrosine phosphatase PTPN1 modulates cell growth and associates with poor outcome in human neuroblastoma.
Nunes-Xavier CE; Aurtenetxe O; Zaldumbide L; López-Almaraz R; Erramuzpe A; Cortés JM; López JI; Pulido R
Diagn Pathol; 2019 Dec; 14(1):134. PubMed ID: 31837707
[TBL] [Abstract][Full Text] [Related]
23. Role of urokinase plasminogen activator and its receptor in metastasis and invasion of neuroblastoma.
Li P; Gao Y; Ji Z; Zhang X; Xu Q; Li G; Guo Z; Zheng B; Guo X
J Pediatr Surg; 2004 Oct; 39(10):1512-9. PubMed ID: 15486896
[TBL] [Abstract][Full Text] [Related]
24. DUSP5 expression associates with poor prognosis in human neuroblastoma.
Aurtenetxe O; Zaldumbide L; Erramuzpe A; López R; López JI; Cortés JM; Pulido R; Nunes-Xavier CE
Exp Mol Pathol; 2018 Dec; 105(3):272-278. PubMed ID: 30171833
[TBL] [Abstract][Full Text] [Related]
25. MYCN-regulated microRNAs repress estrogen receptor-alpha (ESR1) expression and neuronal differentiation in human neuroblastoma.
Lovén J; Zinin N; Wahlström T; Müller I; Brodin P; Fredlund E; Ribacke U; Pivarcsi A; Påhlman S; Henriksson M
Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1553-8. PubMed ID: 20080637
[TBL] [Abstract][Full Text] [Related]
26. FUBP1 promotes neuroblastoma proliferation via enhancing glycolysis-a new possible marker of malignancy for neuroblastoma.
Jiang P; Huang M; Qi W; Wang F; Yang T; Gao T; Luo C; Deng J; Yang Z; Zhou T; Zou Y; Gao G; Yang X
J Exp Clin Cancer Res; 2019 Sep; 38(1):400. PubMed ID: 31511046
[TBL] [Abstract][Full Text] [Related]
27. Dihydropyrimidinase-like protein 3 expression is negatively regulated by MYCN and associated with clinical outcome in neuroblastoma.
Tan F; Wahdan-Alaswad R; Yan S; Thiele CJ; Li Z
Cancer Sci; 2013 Dec; 104(12):1586-92. PubMed ID: 24011394
[TBL] [Abstract][Full Text] [Related]
28. Targeted inhibition of MEK1 by cobimetinib leads to differentiation and apoptosis in neuroblastoma cells.
Singh A; Ruan Y; Tippett T; Narendran A
J Exp Clin Cancer Res; 2015 Sep; 34(1):104. PubMed ID: 26384788
[TBL] [Abstract][Full Text] [Related]
29. MicroRNAs define distinct human neuroblastoma cell phenotypes and regulate their differentiation and tumorigenicity.
Samaraweera L; Grandinetti KB; Huang R; Spengler BA; Ross RA
BMC Cancer; 2014 May; 14():309. PubMed ID: 24885481
[TBL] [Abstract][Full Text] [Related]
30. Arsenic trioxide induces the differentiation of retinoic acid-resistant neuroblastoma cells via upregulation of HoxC9.
Li C; Feng C; Chen Y; Wu P; Li P; Xiong X; Peng X; Wang Z; Li Y
Adv Clin Exp Med; 2022 Aug; 31(8):903-911. PubMed ID: 35467087
[TBL] [Abstract][Full Text] [Related]
31. International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
Shimada H; Umehara S; Monobe Y; Hachitanda Y; Nakagawa A; Goto S; Gerbing RB; Stram DO; Lukens JN; Matthay KK
Cancer; 2001 Nov; 92(9):2451-61. PubMed ID: 11745303
[TBL] [Abstract][Full Text] [Related]
32. Krüppel-like factor 9 promotes neuroblastoma differentiation via targeting the sonic hedgehog signaling pathway.
Chen S; Gu S; Xu M; Mei D; Xiao Y; Chen K; Yan Z
Pediatr Blood Cancer; 2020 Mar; 67(3):e28108. PubMed ID: 31782614
[TBL] [Abstract][Full Text] [Related]
33. PRAF2 stimulates cell proliferation and migration and predicts poor prognosis in neuroblastoma.
Yco LP; Geerts D; Koster J; Bachmann AS
Int J Oncol; 2013 Apr; 42(4):1408-16. PubMed ID: 23440329
[TBL] [Abstract][Full Text] [Related]
34. BLM germline and somatic PKMYT1 and AHCY mutations: Genetic variations beyond MYCN and prognosis in neuroblastoma.
Novak EM; Halley NS; Gimenez TM; Rangel-Santos A; Azambuja AM; Brumatti M; Pereira PL; Vince CS; Giorgi RR; Bendit I; Cristofani LM; Odone-Filho V
Med Hypotheses; 2016 Dec; 97():22-25. PubMed ID: 27876123
[TBL] [Abstract][Full Text] [Related]
35. A novel metastatic animal model reflecting the clinical appearance of human neuroblastoma: growth arrest of orthotopic tumors by natural, cytotoxic human immunoglobulin M antibodies.
Engler S; Thiel C; Förster K; David K; Bredehorst R; Juhl H
Cancer Res; 2001 Apr; 61(7):2968-73. PubMed ID: 11306475
[TBL] [Abstract][Full Text] [Related]
36. Krüppel-like factor 4 (KLF4) suppresses neuroblastoma cell growth and determines non-tumorigenic lineage differentiation.
Shum CK; Lau ST; Tsoi LL; Chan LK; Yam JW; Ohira M; Nakagawara A; Tam PK; Ngan ES
Oncogene; 2013 Aug; 32(35):4086-99. PubMed ID: 23045286
[TBL] [Abstract][Full Text] [Related]
37. Long Noncoding RNA NHEG1 Drives β-Catenin Transactivation and Neuroblastoma Progression through Interacting with DDX5.
Zhao X; Li D; Yang F; Lian H; Wang J; Wang X; Fang E; Song H; Hu A; Guo Y; Liu Y; Li H; Chen Y; Huang K; Zheng L; Tong Q
Mol Ther; 2020 Mar; 28(3):946-962. PubMed ID: 31982037
[TBL] [Abstract][Full Text] [Related]
38. Metabolomic profiling in neuroblastoma.
Quintás G; Yáñez Y; Gargallo P; Juan Ribelles A; Cañete A; Castel V; Segura V
Pediatr Blood Cancer; 2020 Mar; 67(3):e28113. PubMed ID: 31802629
[TBL] [Abstract][Full Text] [Related]
39. Recent advances in the developmental origin of neuroblastoma: an overview.
Ponzoni M; Bachetti T; Corrias MV; Brignole C; Pastorino F; Calarco E; Bensa V; Giusto E; Ceccherini I; Perri P
J Exp Clin Cancer Res; 2022 Mar; 41(1):92. PubMed ID: 35277192
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-149 is associated with clinical outcome in human neuroblastoma and modulates cancer cell proliferation through Rap1 independent of MYCN amplification.
Xu Y; Chen X; Lin L; Chen H; Yu S; Li D
Biochimie; 2017 Aug; 139():1-8. PubMed ID: 28456710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
